Benzinga's Top Downgrades
Analysts at Morgan Stanley downgraded Expedia Inc (NASDAQ: EXPE) from “equal-weight” to “underweight.” Expedia's shares closed at $28.84 yesterday. Expedia's trailing-twelve-month ROA is 6.65%.
The Benchmark Company downgraded American Science & Engineering Inc (NASDAQ: ASEI) from “hold” to “sell.” ASEI's shares closed at $72.35 yesterday. ASEI's trailing-twelve-month profit margin is 15.11%.
Analysts at Robert W. Baird downgraded Vertex Pharmaceuticals Inc (NASDAQ: VRTX) from “outperform” to “neutral.” VRTX's shares closed at $33.22 yesterday. Vertex Pharmaceuticals' trailing-twelve-month ROE is -47.41%.
Analysts at Oppenheimer downgraded OmniVision Technologies Inc (NASDAQ: OVTI) from “outperform” to “perform.” OVTI's shares closed at $14.26 yesterday. OmniVision Technologies' trailing-twelve-month ROA is 9.52%.
